Snowman Logistics partners with Dr Reddy's for Sputnik vaccine across India

Snowman said it has entered in a strategic partnership with Dr Reddy's to provide end-to-end logistics solutions for delivery of the two-dose Sputnik Covid-19 vaccine across India

Sputnik V, vaccination, vaccine, coronavirus, covid-19, Dr Reddy's Lab
An official of Dr Reddy’s Laboratories getting the first shot of Sputnik V administered in India | Photo: Twitter
ANI
2 min read Last Updated : Jun 03 2021 | 11:25 AM IST

Integrated temperature-controlled logistics service provider Snowman said on Thursday it has entered in a strategic partnership with Dr Reddy's to provide end-to-end logistics solutions for delivery of the two-dose Sputnik Covid-19 vaccine across India.

Snowman will manage the delivery through five of its high-capacity temperature-controlled warehouses in Mumbai, Delhi-NCR, Kolkata, Chennai, and Bengaluru. The company will offer storage, order processing, shipper packing and secondary transportation from these locations.

The locations are strategically located to take care of not just state distribution but the whole of regional requirements. The temperature throughout will be maintained between minus 20 degrees Celsius and minus 25 degrees Celsius.

"We are hopeful of carrying a seamless drive from these warehouses through our fleet of refrigerated vehicles maintaining requisite temperatures throughout the delivery cycle," said Chief Executive Officer Sunil Nair.

With this, Snowman will be the largest 3PL service provider for vaccines in the country offering national reach to Dr Reddy's Lab.

The company said that it has the capability to readily store 65 crore doses at any given time which can be increased to 105 crore doses with a short notice for pan-India distribution.

It also has the ability to store at upto minus 80 degrees Celsius and provides real-time temperature monitoring to ensure correct conditions for vaccine distribution during the entire supply chain.

In addition, the company has a capex plan of Rs 425 crore for capacity expansion, with a focus on pharma and e-commerce sectors where the company has seen huge increases in demand since the onset of pandemic, especially as there is a dearth of capacities in the organised sector, said Snowman.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineDr Reddy’s Laboratories Snowman Logistics

First Published: Jun 03 2021 | 11:24 AM IST

Next Story